Drug intelligence / Profile preview

Jieyu Pingchuan Tang

Development stage: Unknown
Lead developer: The First Affiliated Hospital of the University of South China
Administration: Oral

Overview

Jieyu Pingchuan Tang is a Traditional Chinese Medicine (TCM) herbal decoction developed by The First Affiliated Hospital of South China University for the treatment of mild to moderate chronic persistent asthma. The formula is specifically designed for patients exhibiting "liver depression syndrome," a TCM pattern characterized by qi stagnation. It aims to provide therapeutic benefit by simultaneously addressing respiratory symptoms (wheezing and cough) and the underlying emotional or systemic stagnation associated with the liver meridian. In clinical study ChiCTR2400089119, it is evaluated as an add-on therapy to standard Western medical treatment to assess its efficacy in improving asthma control and lung function.

Other names: Jieyu Pingchuan Decoction

Beyond the preview

Go deeper on Jieyu Pingchuan Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jieyu Pingchuan Tang.

Explore the full profile